Inland Rheumatology Clinical Trials Inc. — Upland, California

Public research footprint of Inland Rheumatology Clinical Trials Inc., compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Systemic Lupus Erythematosus · Rheumatoid Arthritis · Subacute Cutaneous Lupus Erythematosus · Chronic Cutaneous Lupus Erythematosus

Recently updated registry entries

NCT07438496 — A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus (Recruiting)
NCT06741969 — Nipocalimab in Moderate to Severe Sjogren's Disease (Active Not Recruiting)
NCT05531565 — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Inland Rheumatology Clinical Trials Inc.?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.